The Global Digital Pharmacy Market by Drug (Rx, OTC), Product (Medicine, Personal Care, Vitamins & Supplements, Diabetes, CVD, Oncology), Platform (Apps, Websites), Business Model (Captive, Franchise, Aggregator), Geographic (Urban, Rural) – Global Forecasts to 2027″, is projected to reach USD 211.9 billion by 2027 from USD 96.5 billion in 2022, at a CAGR of 17.0% during the forecast period
The growth of this market is driven by the increasing consumer preference toward buying online medicines during and post the COVID-19 pandemic, consolidation in the market and partnerships, and the growing geriatric population.
However, patients relying on pharmacists for clinical support and a growing number of illegal pharmacies are expected to restrain the growth of this market during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134868253
Browse in-depth TOC on “Digital Pharmacy Market”
175 – Tables
36 – Figures
224 – Pages
Key Market Player
Prominent players in this market are CVS Health (US), Cigna (US), Optum, Inc. (Part of the UnitedHealth Group) (US), Walgreens Co. (US), Walmart Inc. (US), The Kroger Co. (US), Amazon.com, Inc. (US), GoodRx (US), Costco Wholesale Corporation (US), Rite Aid Corp. (US), Hims & Hers Health, Inc. (US), PharmEasy (India), Apollo Pharmacy (India), DocMorris (Netherlands), Giant Eagle Inc. (US), LloydsPharmacy (UK), Shop-apotheke.com (Netherlands), Tata 1mg (India), Netmeds.com (India), HealthWarehouse, Inc. (US), Pharmex Direct Inc. (Canada), Apex Pharmacy (UK), TELUS (Canada), RO Pharmacy (US), Rx Outreach (US), The Independent Pharmacy (UK), Rexall Pharmacy Group ULC (Canada), and NorthWestPharmacy.com (Canada). These players are increasingly focusing on product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations to expand their product offerings in the digital pharmacy market.
Digital Pharmacy Market Dynamics
How growth of consumer preference towards buying online medicines increased during and the post COVID-19 ?
COVID-19 is one of the leading social and health challenges of our time. The ongoing pandemic has forced a drastic transformation of life at every level of society. The high infection rate of COVID-19 led to an increased demand for medication in hospitals and home care settings. COVID-19 has changed the way in which businesses are conducted. Consumer attitudes, behaviors, and purchasing habits have all changed and many of these new patterns will remain post-pandemic. Nationwide lockdowns during the pandemic forced people to stay indoors. This pushed people to switch to online channels for the purchase of goods & services as well as to pay bills and consult with doctors. According to the FICCI 2020 report, more than 75% of all consumers cited that their online pharmacy purchases either increased or remained the same. This changing consumer behavior is expected to drive the market for digital pharmacy solutions in the coming years.
Inquire Before Buying this Reports:https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134868253
How is growing illegal pharmacies restraining growth of the market?
Illegal internet pharmacies are often international operations with servers, shipping operations, and other parts of the business located in several countries. The WHO emphasizes that substandard and falsified products may result in patient harm and suboptimal treatment, leading to an overall mistrust of medications, healthcare providers and the health system. In 2021, the FDA issued warning letters to website operators engaged in illegal activity in violation of the US Federal Food, Drug, and Cosmetic Act. Consumers seeking overseas options to obtain medicines also pose a threat to the pharmaceutical industry and pharmacists of the respective country. Such illegal buying behaviors can result in the loss of credibility and faith in online medicine and may hinder the greater adoption of digital pharmacy solutions globally
Why is lack of strong national laws worldwide a critical challenging factor that is holding back growth of market?
According to the International Society for Pharmaceutical Engineering 2019, 66% of countries worldwide do not have laws that explicitly regulate or prohibit the online sales of medicinal products. As a result, regulatory authorities in these countries are only able to employ the “buyers beware” approach so that consumers remain vigilant when buying medicinal products online. The Federal Bureau of Investigation (FBI) estimated that there are more than 80,000 websites that allow individuals to place medication orders through illegal pharmacies. Customers choose to utilize online pharmacies over traditional brick-and-mortar pharmacies for a variety of reasons, including accessibility, time constraints, and potential cost savings. In Nigeria, the body responsible for licensing pharmacies, the Pharmacy Council of Nigeria, has developed rules to guide the regulatory process for e-pharmacies in 2016, but they have not yet been made public. Until an international legal framework is formed and agreed upon, illegal pharmacies will continue to expand and inappropriately dispense medications to consumers. This may hinder the growth of the digital pharmacy market in low-income and middle-income countries (LMICs).
What opportunities does increase in the emerging market?
Emerging economies are expected to become a focal point for growth in the digital pharmacy market. Developing countries possess a high geriatric population. In China, the population of individuals aged 65 years and above was estimated to be 131.4 million in 2015 and was expected to grow by 29.0% to reach 169.6 million by 2020 (Source: The United Nations Population Division Statistics). As the elderly are more susceptible to diseases, the rising geriatric population is expected to drive patient volumes in several countries across the globe. This, in turn, will increase the demand for digital pharmacy solutions. The developing economies, growing government support, rising life science research, and improving healthcare infrastructure in China, Korea, and India also compel pharmacies in these countries to opt for online platforms. Due to these factors, major players are investing in the Asia Pacific region.
“North America to dominate the digital pharmacy market in 2022”.
North America accounted for the largest share of the digital pharmacy market. The increasing prevalence of chronic conditions, the rising number of drug prescriptions resulting from the rapidly growing aging population, and the presence of key market players in the region are the key factors driving the growth of the digital pharmacy market in North America.
Report Objectives:
- To define, describe, segment, analyze, and forecast the digital pharmacy market based on drug type, product, platform, business model, geographic coverage, and region
- To provide detailed information regarding the drivers, restraints, opportunities, challenges, and industry trends influencing the growth of the digital pharmacy market
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze the opportunities in the digital pharmacy for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the global digital pharmacy market with respect to five main regions (along with countries)& North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To strategically profile the key players in this market and comprehensively analyze their market shares and core competencies
- To track and analyze competitive developments such as product/service upgrades, acquisitions, partnerships, agreements, expansions, and collaborations in the digital pharmacy market during the forecast period
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=134868253
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/digital-pharmacy-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/digital-pharmacy.asp
